Meet our Director, Dr. Ronald Perrone
Led by Ronald Perrone, MD, our team of nephrologists and other specialists provide the best — and most advanced — PKD care. Throughout Dr. Perrone's career, he has consistently been recognized for his excellence in clinical care and research. U.S. News & World Report has designated him a "Top Doctor" and ranked him among the top 1% of the nation's nephrologists.
Dr. Perrone and his team are at the forefront of PKD research, and we bring the latest treatments right to you. Our physicians and patients participate in the nation's most advanced clinical trials including tesevatinib (Kadmon), metformin (TAME), bardoxolone (FALCON, Reata), and venglustat (STAGED-PKD, Sanofi).. For example, Tufts MC is one of only seven centers in the country to be part of the groundbreaking HALT-PKD study, which aims to slow the progression of the disease.
